Cystic fibrosis
CFTR modulators that transformed survival in cystic fibrosis.
- Trials
- 1
- Years
- 2019
Sort
- 2019ELX/TEZ/IVA CoreCFTR modulatorIn 403 patients ≥12 years with CF carrying one F508del and one minimal-function mutation, elexacaftor-tezacaftor-ivacaftor improved ppFEV1 and exacerbation rate compared with placebo.Read →